StockData

Dianthus Therapeutics, Inc. (DNTH) income statement

DNTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$83.98−3.00 (-3.45%)

Close on Nov 18, 2026Market cap $4.70BP/E –Yield 0.00%

See a number that looks wrong?